PKDL Consortium meeting Kolkata, 28-29 November 2024

The Post-kala-azar dermal leishmaniasis (PKDL) Consortium was founded in 2012;  the 7th meeting was held in Kolkata, India. The Consortium aims to promote all aspects of PKDL both with regard to clinical management as well as control.

In the meeting, epidemiology and control, immunology, vaccines and immunotherapy, leishmania and co-infection, diagnosis and treatment were reviewed.

Kolkata meeting agenda, 23112024(1)

The meeting was covered in one of the local newspapers:

https://epaper.telegraphindia.com/calcutta/2024-11-29/71/Page-8.html

 

 

Introduction slides

To archive

Recent publications

Tiggelaar IG, Janszen EWM, van Elteren M, Flinkenflögel MM, Sherally J, Hofland HWC, van Loey NEE, Zijlstra EE. Dutch post-graduate training in Global Health and Tropical Medicine: a qualitative study on graduates' perspectives. BMC Med Educ. 2025 May 6;25(1):663. doi: 10.1186/s12909-025-07126-6. PMID: 40329278; PMCID: PMC12057042.
Increasing experience in the use of papaya for burn injuries in an African context, potential and limitations
Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial
View all publications

Blog

PKDL Consortium meeting Kolkata, 28-29 November 2024

The Post-kala-azar dermal leishmaniasis (PKDL) Consortium was founded in 2012;  the 7th meeting was held in Kolkata, India. The Consortium aims to promote all aspects of PKDL both with

> Read more